VITT with inactivated SARS-CoV-2 vaccine–index case

Kanta Devi; Natasha Ali; Nosheen Nasir; Syed Faisal Mahmood

doi:10.1080/21645515.2022.2036556

VITT with inactivated SARS-CoV-2 vaccine–index case

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Abstract

We report a case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a 73-year-old gentleman who presented with pulmonary embolism and thrombocytopenia, two weeks after receiving inactivated COVID-19 vaccine. He responded well to nonheparin anticoagulation with complete resolution of symptoms and platelet count.

Original language	English (US)
Article number	2036556
Journal	Human Vaccines and Immunotherapeutics
Volume	18
Issue number	1
DOIs	https://doi.org/10.1080/21645515.2022.2036556
Publication status	Published - 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

COVID-19
VITT
inactivated vaccine

Access to Document

10.1080/21645515.2022.2036556

Cite this

@article{8f699b7b332545cab837b7d89b498400,

title = "VITT with inactivated SARS-CoV-2 vaccine–index case",

abstract = "We report a case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a 73-year-old gentleman who presented with pulmonary embolism and thrombocytopenia, two weeks after receiving inactivated COVID-19 vaccine. He responded well to nonheparin anticoagulation with complete resolution of symptoms and platelet count.",

keywords = "COVID-19, VITT, inactivated vaccine",

author = "Kanta Devi and Natasha Ali and Nosheen Nasir and Mahmood, \{Syed Faisal\}",

note = "Publisher Copyright: {\textcopyright} 2022 The Author(s). Published with license by Taylor \& Francis Group, LLC.",

year = "2022",

doi = "10.1080/21645515.2022.2036556",

language = "English (US)",

volume = "18",

journal = "Human Vaccines and Immunotherapeutics",

issn = "2164-5515",

publisher = "Taylor and Francis Ltd.",

number = "1",

}

TY - JOUR

T1 - VITT with inactivated SARS-CoV-2 vaccine–index case

AU - Devi, Kanta

AU - Ali, Natasha

AU - Nasir, Nosheen

AU - Mahmood, Syed Faisal

PY - 2022

Y1 - 2022

N2 - We report a case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a 73-year-old gentleman who presented with pulmonary embolism and thrombocytopenia, two weeks after receiving inactivated COVID-19 vaccine. He responded well to nonheparin anticoagulation with complete resolution of symptoms and platelet count.

AB - We report a case of vaccine-induced immune thrombotic thrombocytopenia (VITT) in a 73-year-old gentleman who presented with pulmonary embolism and thrombocytopenia, two weeks after receiving inactivated COVID-19 vaccine. He responded well to nonheparin anticoagulation with complete resolution of symptoms and platelet count.

KW - COVID-19

KW - VITT

KW - inactivated vaccine

UR - https://www.scopus.com/pages/publications/85126245065

U2 - 10.1080/21645515.2022.2036556

DO - 10.1080/21645515.2022.2036556

M3 - Article

C2 - 35254213

AN - SCOPUS:85126245065

SN - 2164-5515

VL - 18

JO - Human Vaccines and Immunotherapeutics

JF - Human Vaccines and Immunotherapeutics

IS - 1

M1 - 2036556

ER -

VITT with inactivated SARS-CoV-2 vaccine–index case

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this